Recent developments in gastroesophageal reflux disease and Barrett's esophagus: ANNO 2012

Journal of Digestive Diseases

Volumn 13, Issue 6, 2012, Pages 291-295

  Tytgat, Guido N J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; Gastroesophageal reflux

Indexed keywords

AGN 201904; ANTACID AGENT; BENATOPRAZOLE; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TAK 390MR; UNCLASSIFIED DRUG;

ARTICLE; AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; CONFOCAL LASER MICROSCOPY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS RESECTION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LIFESTYLE MODIFICATION; NARROW BAND IMAGING; PREVALENCE; PRIORITY JOURNAL; STOMACH PH; SURVIVAL RATE; SURVIVAL TIME;

BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; HUMANS; PRECANCEROUS CONDITIONS; PREVALENCE; PROTON PUMP INHIBITORS;

EID: 84861557096     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2012.00598.x     Document Type: Article

References (11)

1. McColl KE, Clarke A, Seenan J. Acid pocket, hiatus hernia and acid reflux. Gut 2010; 59: 430-1.
2. Boeckxstaens GE, Smout A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2010; 32: 334-43.
3. Boecxstaens V, Bisschops R, Blondeau K etal. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. Aliment Pharmacol Ther 2011; 33: 1370-7.
4. Schubert ML. Gastric secretion. Curr Opin Gastroenterol 2011; 27: 536-42.
5. Scarpignato C, Hunt RH. Proton pump inhibitors: the beginning of the end or the end of the beginning? Curr Opin Pharmacol 2008; 8: 677-84.
6. Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 2010; 10: 87-101.
7. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-83.
8. Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg 2011; 254: 67-72.
9. Garman KS, Shaheen NJ. Ablative therapies for Barrett's esophagus. Curr Gastroenterol Rep 2011; 13: 226-39.
10. Abu-Sneineh A, Tam W, Schoeman M etal. The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus. Aliment Pharmacol Ther 2010; 32: 1023-30.
11. Gordon V, Jankowski J. Chemoprevention in Barrett's oesophagus. Best Pract Res Clin Gastroenterol 2011; 25: 569-79.